Abivax ABVX
NASDAQ ABVX
$93.49 +0.90 (+0.97%)
At close: Oct 21, 2026 · 4:00 PM EDT

Abivax (ABVX) Current Deferred Tax Assets (2026)

Updated

Abivax's Current Deferred Tax Assets was $266,930 in Q1 2026.

Analysis

Abivax (ABVX) Current Deferred Tax Assets (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Abivax 6.50 Bn 4.14 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 261,288.09
API Access

Abivax Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=ABVX&period=max&api_key=YOUR_API_KEY